Palisade Bio, Inc. (PALI)

Palisade Bio Statistics

Total Valuation

Palisade Bio has a market cap or net worth of $257.78 million. The enterprise value is $252.76 million.

Market Cap	257.78M
Enterprise Value	252.76M

Important Dates

The next estimated earnings date is Monday, March 23, 2026, after market close.

Earnings Date	Mar 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Palisade Bio has 149.00 million shares outstanding. The number of shares has increased by 367.35% in one year.

Current Share Class	149.00M
Shares Outstanding	149.00M
Shares Change (YoY)	+367.35%
Shares Change (QoQ)	+55.80%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	36.03%
Float	102.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.91
P/TBV Ratio	80.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.07.

Current Ratio	1.96
Quick Ratio	1.51
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,041.55

Financial Efficiency

Return on equity (ROE) is -228.64% and return on invested capital (ROIC) is -137.86%.

Return on Equity (ROE)	-228.64%
Return on Assets (ROA)	-87.81%
Return on Invested Capital (ROIC)	-137.86%
Return on Capital Employed (ROCE)	-327.81%
Weighted Average Cost of Capital (WACC)	13.08%
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.96% in the last 52 weeks. The beta is 1.61, so Palisade Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	+67.96%
50-Day Moving Average	1.87
200-Day Moving Average	1.29
Relative Strength Index (RSI)	48.44
Average Volume (20 Days)	4,619,778

Short Selling Information

The latest short interest is 21.10 million, so 14.16% of the outstanding shares have been sold short.

Short Interest	21.10M
Short Previous Month	17.50M
Short % of Shares Out	14.16%
Short % of Float	20.64%
Short Ratio (days to cover)	3.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.46M
Pretax Income	-11.23M
Net Income	-11.23M
EBITDA	-11.45M
EBIT	-11.46M
Earnings Per Share (EPS)	-$2.33

Balance Sheet

The company has $5.23 million in cash and $211,000 in debt, with a net cash position of $5.02 million or $0.03 per share.

Cash & Cash Equivalents	5.23M
Total Debt	211,000
Net Cash	5.02M
Net Cash Per Share	$0.03
Equity (Book Value)	3.21M
Book Value Per Share	0.35
Working Capital	3.35M

Cash Flow

Operating Cash Flow	-10.08M
Capital Expenditures	n/a
Free Cash Flow	-10.08M
FCF Per Share	-$0.07

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Palisade Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-367.35%
Shareholder Yield	-367.35%
Earnings Yield	-4.35%
FCF Yield	-3.91%

Analyst Forecast

The average price target for Palisade Bio is $15.00, which is 767.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	767.05%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-59.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 8, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Apr 8, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1